Inositol polyphosphates promote T cell-independent humoral immunity via the regulation of Bruton’s tyrosine kinase

Abstract

T cell-independent (TI) B cell response is critical for the early protection against pathogen invasion. The regulation and activation of Bruton’s tyrosine kinase (Btk) is known as a pivotal step of B cell antigen receptor (BCR) signaling in TI humoral immunity, as observed in patients with X-linked agammaglobulinemia (XLA) experiencing a high incidence of encapsulated bacterial infections. However, key questions remain as to whether a well-established canonical BCR signaling pathway is sufficient to regulate the activity of Btk. Here, we find that inositol hexakisphosphate (InsP6) acts as a physiological regulator of Btk in BCR signaling. Absence of higher order inositol phosphates (InsPs), inositol polyphosphates, leads to an inability to mount immune response against TI antigens. Interestingly, the significance of InsP6-mediated Btk regulation is more prominent in IgM+plasma cells. Hence, the present study identifies higher order InsPs as principal components of B cell activation upon TI antigen stimulation and presents a mechanism for InsP-mediated regulation of the BCR signaling.

Genome-wide Resolution Peripheral Blood Methylome Profiling Reveals Signatures for Cholestatic Liver Disease

“…DMR detection found 100 DMRs, which were associated with 70 unique genes and 6 enriched pathways (phosphatidylinositol signaling, axon guidance, inositol phosphate metabolism, calcium signaling and IL-17 signaling pathway, Figure 2 D). Similar genes are involved in phosphatidylinositol signaling, inositol phosphate metabolism and calcium signaling, which play many crucial roles in diverse cellular functions including immune responses [ 15 , 16 ]. IL-17 signaling is also a key pathway in regulating immunity [ 17 ].…”

Inositol Polyphosphate Multikinase Signaling: Multifaceted Functions in Health and Disease

“…In addition to the direct products of IPMK, its downstream IP products, including IP6, have been suggested to mediate cellular signaling. For example, in IPMK knock-out (KO) murine B cells, reductions in the level of IP6, a cofactor required for Btk kinase activation, impaired Btk activation and B-cell receptor signaling (Kim et al, 2019). The lipid-kinase activity of IPMK (i.e., a PI3-kinase) expands the signaling role of IPMK in mammals (Table 1).…”

“…IPMK is a key determinant in stabilizing TRAF6 by preventing the ubiquitination-dependent proteasomal degradation of this TLR signaling factor, thereby influencing the TLR-induced innate immunity. Bacterial polysaccharides and the repetitive epitopes of viral particles can activate B cells independently of T cells via cross-linking of the antigen receptors (Kim et al, 2019). This process triggers a rapid and robust antibody response to bacterial infection.…”

Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials

“…Moreover, an in vivo study demonstrated the immunomodulatory function of IP6 in B cells. Indeed, IP6 (80 μM) activated T cellindependent humoral immunity by improving B cell antigen receptor (BCR) signaling (W. Kim et al, 2019b).…”